ACADIA Pharmaceuticals (ACAD) stock Forecast for 2022 – 2026

ACADIA Pharmaceuticals (ACAD) stock Forecast for 2022 – 2026

Last update: October 6, 2022 (07:24)

Sector: Healthcare

The share price of ACADIA Pharmaceuticals Inc. (ACAD) now

What analysts predict: $18.88

52-week high/low: $28.06 / $12.24

50/200 Day Moving Average: $16.4 / $19.96

This figure corresponds to the average price over the previous 50/200 days. For ACADIA Pharmaceuticals stocks, the 50-day moving average is the support level today.

For ACADIA Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in ACADIA Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ACADIA Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one ACADIA Pharmaceuticals share be worth in 2022 - 2026?

When should I take profit in ACADIA Pharmaceuticals stock? When should I record a loss on ACADIA Pharmaceuticals stock? What are analysts' forecasts for ACADIA Pharmaceuticals stock? What is the future of ACADIA Pharmaceuticals stock?

We forecast ACADIA Pharmaceuticals stock performance using neural networks based on historical data on ACADIA Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

ACADIA Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ACADIA Pharmaceuticals shares. This happens once a day.



Fresh insight into ACADIA Pharmaceuticals stock

View all analytics

Acadia: Powerful Unfolding Catalysts

Acadia: Powerful Unfolding Catalysts
August 3, 2022

Summary Aside from being launched for Parkinson’s, Nuplazid is potentially gaining two additional label expansions. Trofinetide is also poised to gain FDA approval to treat the rare condition, Rett syndrome … Read more

FDA AdComm Rejects Nuplazid This Time But Acadia’s Race Isn’t Run Yet

FDA AdComm Rejects Nuplazid This Time But Acadia’s Race Isn’t Run Yet
June 29, 2022

Summary Acadia won approval for its only commercialized drug Nuplazid in 2017 and has tried and failed to expand its label since. This month an FDA AdComm voted against an … Read more



Historical and forecast chart of ACADIA Pharmaceuticals stock

The chart below shows the historical price of ACADIA Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ACADIA Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

ACADIA Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Oct 08 18.37 18.22 18.77 3.03
Oct 09 18.12 17.93 18.67 4.17
Oct 10 17.83 17.55 18.36 4.63
Oct 11 17.99 17.50 18.52 5.84
Oct 12 17.67 17.16 18.06 5.23
Oct 13 18.27 17.94 18.66 4.03
Oct 14 18.02 17.85 18.42 3.19
Oct 15 17.72 17.45 17.89 2.52
Oct 16 17.16 16.85 17.37 3.10
Oct 17 17.09 16.74 17.57 4.98
Oct 18 17.05 16.86 17.36 2.99
Oct 19 16.91 16.72 17.43 4.25
Oct 20 16.72 16.21 17.03 5.08
Oct 21 17.35 16.88 17.50 3.70
Oct 22 17.88 17.42 18.09 3.86
Oct 23 18.16 17.72 18.56 4.75
Oct 24 18.19 17.89 18.50 3.38
Oct 25 18.76 18.19 19.16 5.32
Oct 26 19.09 18.76 19.53 4.07
Oct 27 19.46 19.21 19.99 4.05
Oct 28 19.50 19.33 19.96 3.23
Oct 29 19.19 18.94 19.58 3.41
Oct 30 19.26 19.02 19.61 3.08
Oct 31 18.97 18.46 19.44 5.30
Nov 01 18.89 18.60 19.24 3.45
Nov 02 19.32 18.97 19.78 4.24
Nov 03 18.69 18.29 19.09 4.37
Nov 04 18.50 18.01 19.03 5.67
Nov 05 18.85 18.46 19.35 4.82
Nov 06 18.42 18.09 18.64 3.06

ACADIA Pharmaceuticals Daily Price Targets


ACADIA Pharmaceuticals Stock Forecast 10-08-2022.

Forecast target price for 10-08-2022: $18.37. Positive dynamics for ACADIA Pharmaceuticals shares will prevail with possible volatility of 2.937%.

Pessimistic target level: 18.22

Optimistic target level: 18.77


ACADIA Pharmaceuticals Stock Forecast 10-09-2022.

Forecast target price for 10-09-2022: $18.12. Negative dynamics for ACADIA Pharmaceuticals shares will prevail with possible volatility of 3.999%.

Pessimistic target level: 17.93

Optimistic target level: 18.67


ACADIA Pharmaceuticals Stock Forecast 10-10-2022.

Forecast target price for 10-10-2022: $17.83. Negative dynamics for ACADIA Pharmaceuticals shares will prevail with possible volatility of 4.427%.

Pessimistic target level: 17.55

Optimistic target level: 18.36


ACADIA Pharmaceuticals Stock Forecast 10-11-2022.

Forecast target price for 10-11-2022: $17.99. Positive dynamics for ACADIA Pharmaceuticals shares will prevail with possible volatility of 5.517%.

Pessimistic target level: 17.50

Optimistic target level: 18.52


ACADIA Pharmaceuticals Stock Forecast 10-12-2022.

Forecast target price for 10-12-2022: $17.67. Negative dynamics for ACADIA Pharmaceuticals shares will prevail with possible volatility of 4.973%.

Pessimistic target level: 17.16

Optimistic target level: 18.06


ACADIA Pharmaceuticals Stock Forecast 10-13-2022.

Forecast target price for 10-13-2022: $18.27. Positive dynamics for ACADIA Pharmaceuticals shares will prevail with possible volatility of 3.877%.

Pessimistic target level: 17.94

Optimistic target level: 18.66


ACAD (ACAD) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Nov. 18.92 17.31 19.38 10.66
Dec. 19.26 18.29 20.16 9.29

ACADIA Pharmaceuticals forecast for this year


ACADIA Pharmaceuticals Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $18.9212. Pessimistic: $17.31. Optimistic: $19.38


ACADIA Pharmaceuticals Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $19.2618. Pessimistic: $18.29. Optimistic: $20.16




ACADIA Pharmaceuticals (ACAD) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 20.16 19.00 21.23 10.49
Feb 18.61 17.52 20.18 13.17
Mar 18.41 16.96 18.90 10.29
Apr 19.76 18.91 21.07 10.24
May 20.14 19.10 21.76 12.22
Jun 20.55 18.58 22.15 16.14
Jul 20.53 19.57 21.93 10.78
Aug 21.27 19.51 23.26 16.13
Sep 22.36 20.67 23.20 10.88
Oct 21.05 20.47 22.21 7.85
Nov 22.08 20.07 22.88 12.28
Dec 21.45 20.06 22.81 12.07

ACADIA Pharmaceuticals (ACAD) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 21.55 20.41 22.17 7.93
Feb 22.87 21.22 23.91 11.25
Mar 23.34 21.57 24.15 10.67
Apr 22.13 20.78 22.77 8.75
May 21.04 19.76 22.91 13.78
Jun 21.45 19.49 22.81 14.55
Jul 19.88 18.11 20.90 13.35
Aug 20.02 18.58 20.81 10.73
Sep 20.09 18.43 21.59 14.63
Oct 19.59 18.48 20.76 10.98
Nov 19.84 19.23 20.49 6.16
Dec 22.08 20.02 23.65 15.35



ACADIA Pharmaceuticals (ACAD) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 21.13 19.96 22.35 10.67
Feb 20.27 18.81 22.14 15.05
Mar 19.25 18.60 20.22 8.00
Apr 17.70 16.34 18.63 12.31
May 16.45 16.01 16.96 5.59
Jun 16.05 14.72 17.40 15.39
Jul 17.82 16.33 18.74 12.89
Aug 19.51 18.34 20.73 11.52
Sep 18.60 17.55 20.27 13.43
Oct 19.25 17.47 20.03 12.80
Nov 19.43 18.17 20.71 12.27
Dec 19.24 17.91 20.45 12.42

ACADIA Pharmaceuticals (ACAD) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 21.00 19.71 21.86 9.80
Feb 21.55 20.11 22.93 12.30
Mar 19.98 18.90 20.70 8.69
Apr 19.98 18.56 21.53 13.80
May 18.97 17.56 19.81 11.38
Jun 20.61 19.15 21.40 10.52
Jul 20.68 18.90 22.00 14.10
Aug 21.25 20.16 22.53 10.53
Sep 23.37 22.36 24.46 8.60
Oct 24.32 23.10 25.08 7.91
Nov 26.54 24.57 28.23 12.97
Dec 28.36 27.61 31.01 10.97

ACADIA Pharmaceuticals information and performance

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, specializes in the development and commercialization of small molecule drugs designed to meet unmet medical needs in diseases of the central nervous system.

ACADIA Pharmaceuticals Address

3611 VALLEY CENTRE DRIVE, SUITE 300, SAN DIEGO, CA, US

Market Capitalization: 2 647 752 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -204 074 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -0.42

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.334

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 0.168

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.371

Enterprise Value (EV) /Revenue

EV To EBITDA: -10.97

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 161843000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.